ReviewJournal of medical ultrasonics (2001)2025
Contrast-enhanced ultrasound in the evaluation and management of solid renal lesions based on EFSUMB guidelines.
Review in Journal of medical ultrasonics (2001), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Diagnostic evaluation of renal masses in chronic kidney disease: a clinical and radiologic challenge.Abdominal radiology (New York) · 2026Review
- A contrast-enhanced ultrasound-based nomogram for preoperative prediction of pseudocapsule status in localized clear cell renal cell carcinoma: a retrospective study.Translational andrology and urology · 2026Article
- Association Between Abscess Size, Inflammatory Markers, and the Need for Drainage in Renal Abscesses.Diseases (Basel, Switzerland) · 2026Article
- Renal hemangioblastoma mimicking clear cell renal cell carcinoma: a case report emphasizing contrast-enhanced ultrasound findings.BMC nephrology · 2026Article
- High-Resolution Contrast-Enhanced Ultrasound with SRCEUS for Assessing the Intrahepatic Microvasculature and Shunts in Patients with Hereditary Haemorrhagic Teleangiectasia (Osler's Disease).Life (Basel, Switzerland) · 2025Article
- The value of contrast-enhanced ultrasound in the follow-up of Bosniak IIF cystic renal lesions.BMC medical imaging · 2025Article
- Super-Resolution Contrast-Enhanced Ultrasound Examination Down to the Microvasculature Enables Quantitative Analysis of Liver Lesions: First Results.Life (Basel, Switzerland) · 2025Article
- Ultrasound-guided intrarenal arterial injection promotes homing of MSCs and recovery of kidney in Adriamycin-induced nephropathy in rats.Cell transplantationArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Contrast-enhanced ultrasound (CEUS) has become an important tool for the detection and characterization of solid renal lesions, complementing traditional B-mode US, which often struggles to distinguish between solid and cystic masses. CEUS enhances diagnostic accuracy by providing detailed vascularization information, helping to identify potentially malignant solid lesions and differentiate between pseudotumours and solid masses. Moreover, CEUS employs a contrast agent that is safe even for nephropathic patients and can be used without concern for kidney function, making it an advantageous method for renal imaging. In this narrative review, following the European Federation of Societies for Ultrasound in Medicine and Biology guidelines, the authors show its main indications: characterizing indeterminate renal lesions in patients with transplanted kidney, monitoring non-surgical lesions, diagnosing inflammatory-infectious renal pathologies, and assessing advanced renal lesions and masses in the surgical bed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.